Structure Therapeutics (GPCR) Total Liabilities (2022 - 2026)

Structure Therapeutics' Total Liabilities history runs 5 years deep, the most recent figure standing at $61.0 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 45.62% year-over-year to $61.0 million; the TTM figure through Mar 2026 stood at $61.0 million (up 45.62% YoY), while the FY2025 annual figure was $67.5 million, up 75.49% from the prior year.
• Total Liabilities for Q1 2026 stood at $61.0 million, down from $67.5 million in the prior quarter.
• The five-year high for Total Liabilities was $67.5 million in Q4 2025, with the low at $11.0 million in Q1 2023.
• The 5-year median for Total Liabilities is $32.7 million (2023), against an average of $35.5 million.
• Peak annual rise in Total Liabilities reached 149.11% in 2024, while the deepest fall reached 32.48% in 2024.
• Structure Therapeutics' Total Liabilities stood at $13.0 million in 2022, then surged by 123.3% to $29.1 million in 2023, then soared by 32.48% to $38.5 million in 2024, then jumped by 75.49% to $67.5 million in 2025, then declined by 9.64% to $61.0 million in 2026.
• Business Quant data shows GPCR's Total Liabilities at $61.0 million in Q1 2026, $67.5 million in Q4 2025, and $62.1 million in Q3 2025.